Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSINOPRIL vs FREMANEZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSINOPRIL vs FREMANEZUMAB: Safety Overview

Metric FOSINOPRIL FREMANEZUMAB
Total FAERS Reports 461 224
Deaths Reported 36 2
Death Rate 7.8% 0.9%
Hospitalizations 219 39
Average Patient Age 66.1 yrs 47.1 yrs
% Female Patients 41.5% 88.8%
FDA Approval Date Apr 20, 2005 N/A
Manufacturer Chartwell RX, LLC Teva Pharmaceuticals USA, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Discontinued N/A